Published in Biomed Res Int on March 24, 2014
In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. Int J Med Sci (2015) 0.81
Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureus. Biomed Res Int (2015) 0.79
The Search for Herbal Antibiotics: An In-Silico Investigation of Antibacterial Phytochemicals. Antibiotics (Basel) (2016) 0.76
Synergistic Interaction of Methanol Extract from Canarium odontophyllum Miq. Leaf in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 33591. Int J Microbiol (2016) 0.75
Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria. Medicines (Basel) (2016) 0.75
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2008) 8.58
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med (2006) 7.56
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol (2004) 6.65
Synergism between natural products and antibiotics against infectious diseases. Phytomedicine (2008) 2.38
Antibiotic combinations: should they be tested? Clin Microbiol Rev (1988) 2.34
Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.13
Essential oils in combination and their antimicrobial properties. Molecules (2012) 1.99
Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.75
Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res (2007) 1.63
Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis (2007) 1.30
Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy (2005) 1.23
Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis (1993) 1.16
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J Antimicrob Chemother (2009) 1.14
Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci (2011) 1.13
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis (2007) 1.13
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J Antimicrob Chemother (2003) 1.12
Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrob Agents Chemother (2011) 1.09
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (2008) 1.07
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol (2010) 1.05
Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay. Antimicrob Agents Chemother (2010) 1.05
Investigation of monomeric and oligomeric wine stilbenoids in red wines by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2013) 1.00
Polymyxins: Antimicrobial susceptibility concerns and therapeutic options. Indian J Med Microbiol (2011) 0.98
Quinolones sensitize gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother (2006) 0.97
The antimicrobial activity of compounds from the leaf and stem of Vitis amurensis against two oral pathogens. Bioorg Med Chem Lett (2009) 0.93
Prevalence and antibiotic resistance pattern of methicillin-resistant Staphylococcus aureus from an orthopaedic hospital in Nigeria. Biomed Res Int (2013) 0.86
Synergistic interaction of phenylpropanoids with antibiotics against bacteria. J Med Microbiol (2010) 0.85
Is in vitro antibiotic combination more effective than single-drug therapy against anthrax? Antimicrob Agents Chemother (2005) 0.85
In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii. Exp Ther Med (2013) 0.84
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2010) 0.83
The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo. Int J Mol Sci (2013) 0.82
Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae. J Clin Med Res (2013) 0.82
Pharmacodynamic Interaction of Quercus infectoria Galls Extract in Combination with Vancomycin against MRSA Using Microdilution Checkerboard and Time-Kill Assay. Evid Based Complement Alternat Med (2012) 0.81
Linezolid: a new antibiotic. Drugs Today (Barc) (2000) 0.79
Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci. Chin Med J (Engl) (2013) 0.77
Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA). Pharmaceuticals (Basel) (2012) 0.76
Evaluation of Analgesic Activity of the Methanol Extract from the Galls of Quercus infectoria (Olivier) in Rats. Evid Based Complement Alternat Med (2014) 0.80